Comment by girvo

I'm sort of conflicted. I feel that the profits that the pharmaceutical companies receive from first world developed countries coupled with the strong IP protection they enjoy here should be good enough, and I'm happy those in other countries receive the care they need. But then, China, India, they have a lot of very rich people too, so to pull it off in a way that to a first approximation makes sense, means some odd regulation and making it harder for people to get it in general without going through hoops. I don't know... Drugs are such a weird thing to think about: we're talking about peoples lives here, and as far as I'm concerned human life is the most important thing in the world, and profiteering from that in the way that pharma companies do sometimes (ever greening, and the like) is unethical in my opinion, the research that they conduct creates a lot of value. Truly, I don't know the correct way of thinking about pharmaceutical companies and business. Hard topic.